Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ August 13, 2022 ] Team Leader, Manufacturing Sciences – Thermo Fisher Scientific – West Hills, CA Los Angeles Biotech Jobs
  • [ August 13, 2022 ] Medical Liaison – MDxHealth Inc. – Irvine, CA Los Angeles Biotech Jobs
  • [ August 13, 2022 ] Supervising Computer Scientist – USC – Los Angeles, CA Los Angeles Biotech Jobs
  • [ August 13, 2022 ] Senior Data Scientist – Biomarker Discovery and Integrating Omics (US-REMOTE) – Amgen – Thousand Oaks, CA Los Angeles Biotech Jobs
  • [ August 13, 2022 ] Associate Scientist – Protein Chemistry – Amgen – Thousand Oaks, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsSTAT+: A U.S. court ruling may force biologics makers to review patent protections

STAT+: A U.S. court ruling may force biologics makers to review patent protections

February 25, 2021 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on STAT+: A U.S. court ruling may force biologics makers to review patent protections
A U.S. appeals court recently restricted wide-ranging patent claims for antibody treatments, a ruling that could have broad implications for the pharmaceutical industry.

Click to view original post

Previous

Sean Nolan gathers AveXis alumni to launch another biotech. Is it another race-to-IPO?

Next

Puma Biotechnology and Pierre Fabre Amend NERLYNX® License Agreement to Include Greater China

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered